Notably, the MS of H3.3-G34R pHGG–implanted CD8-KO mice with no treatment was significantly reduced when compared with that of C57BL/6 (WT) mice (Figure 12F), which indicates that the adaptive immune system played a role in delaying H3.3-G34R pHGG tumor growth. This evidence concerns the gene CD8A and neoplasm.